Primary cutaneous follicle centre lymphoma physical examination: Difference between revisions
No edit summary |
No edit summary |
||
Line 28: | Line 28: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category: | [[Category:Oncology]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Revision as of 16:47, 3 March 2016
Primary cutaneous follicle centre lymphoma Microchapters |
Differentiating Primary cutaneous follicle centre lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Primary cutaneous follicle centre lymphoma physical examination On the Web |
American Roentgen Ray Society Images of Primary cutaneous follicle centre lymphoma physical examination |
FDA on Primary cutaneous follicle centre lymphoma physical examination |
CDC on Primary cutaneous follicle centre lymphoma physical examination |
Primary cutaneous follicle centre lymphoma physical examination in the news |
Blogs on Primary cutaneous follicle centre lymphoma physical examination |
Directions to Hospitals Treating Splenic marginal zone lymphoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Common physical examination findings of primary cutaneous follicle centre lymphoma include fever, rash, ulcer, firm erythematous or violaceous plaques, nodules, or tumors of varying sizes, chest tenderness, abdomen tenderness, bone tenderness, peripheral lymphadenopathy, and central lymphadenopathy.[1]
Physical Examination[1]
Vitals
- Fever is often present
Skin
HEENT
Thorax
- Thoracic masses suggestive of central lymphadenopathy
- Chest tenderness
Abdomen
- Abdominal masses suggestive of central lymphadenopathy
- Abdomen tenderness
Extremities
- Peripheral lymphadenopathy
- Bone tenderness
References
- ↑ 1.0 1.1 Primary cutaneous follicle centre lymphoma. Surveillance, Epidemiology, and End Results Program.http://seer.cancer.gov/seertools/hemelymph/51f6cf5ae3e27c3994bd549b/. Accessed on February 29, 2016